Nektar Therapeutics (NKTR) Halted Ahead of FDA Meeting on Cardio Risks of Opioid Receptor Antagonists
Tweet Send to a Friend
Nektar Therapeutics (NASDAQ: NKTR) announced that NASDAQ has halted trading of the company's common stock.The U.S. Food and Drug Administration's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
